Ann Short Rep | Volume 2, Issue 3 | Review Article | Open Access
Hasan Hosainzadegan*
Department of Basic Sciences, Maragheh University of Medical Sciences, Iran
*Correspondance to: Hasan Hosainzadegan
Fulltext PDFRole of Gut Microbiota (GM) in the emerging of Metabolic Syndrome (MS) related pathologies including type 2 diabetes mellitus, metabolism of lipids and carbohydrates or obesity have been discussed in recent years. The aim of this chapter is to review and explain the different aspects of the effects of changes in the microbial populations of gut in normal and disease states of human and animal studies. Results of recent studies indicates that many of MS related diseases arising from imbalances in the ratio of beneficial (probiotics bacteria) and detrimental microbial population in the gut. Anti-diabetic effects of known probiotics including bifidobacterium and lactobacillus have also been reviewed in this chapter. Finally challenges of previously known diabetes risk factors have been explained in the continuation of chapter based on the new facts in the literature. It seems that risk factors like obesity and aging are the results of imbalance in guts beneficial bacteria not as a risk factor for induction of diabetes. Certainly, with comprehensive studies in the future, the role of beneficial bacteria would be illustrated clearly in MS pathologies, which in turn could draw the definitive treatment strategies of diseases including diabetes.
Hosainzadegan H. Gut Microbiota and Metabolic Syndrome (Diabetes). Ann Short Reports. 2019;2:1040.